|
Steroid naive
|
Steroid treated
|
Number | 16 | 16 |
Sex (M/F) | 9/7 | 7/9 |
Age (years) | 27.8 (22.1–38.2) | 34.3 (25.4–45.2)1-150 |
FEV1(% predicted) | 94.2 (78.8–110.9) | 86.8 (51.0–107.8) |
Mean morning PEF (l/min) | 492 (377–616) | 463 (241–645) |
PEF variability (%) | 7.5 (2.0–17.0) | 13.1 (1.5–25.5)1-150
|
β2 agonist usage (puffs/day) | 0.4 (0.0–3.2) | 1.4 (0.0–10.9) |
Asthma symptom score1-151
| 0.1 (0.00–0.80) | 0.4 (0.00–2.00) |
Exhaled NO (ppb) | 12.5 (3.70–29.30) | 6.90 (2.50–61.00)1-150 |
Mucosal histology MBP+ve cells/HPF (eosinophils) | 1.1 (0.0–7.5) | 2.3 (0.0–6.8) |